Efficacy and safety of HCV-treatment with direct-acting antiviral agents interferon-free, in patients with severe renal impairment in clinical practice
| UDC.coleccion | Investigación | es_ES |
| UDC.conferenceTitle | International Liver Congress | es_ES |
| UDC.departamento | Fisioterapia, Medicina e Ciencias Biomédicas | es_ES |
| UDC.grupoInv | Enfermidades Infecciosas: Hepatite e SIDA | es_ES |
| UDC.issue | Supplement 2 | es_ES |
| UDC.journalTitle | Journal of Hepatology | es_ES |
| UDC.startPage | S779 | es_ES |
| UDC.volume | 64 | es_ES |
| dc.contributor.author | Cabezas, Joaquín | |
| dc.contributor.author | Londoño, M.C. | |
| dc.contributor.author | Llerena, S. | |
| dc.contributor.author | Muñoz-Gómez, R. | |
| dc.contributor.author | Baliellas, Carme | |
| dc.contributor.author | Buti, M. | |
| dc.contributor.author | Pascasio Acevedo, Juan Manuel | |
| dc.contributor.author | Sáez-Royuela, F. | |
| dc.contributor.author | García-Samaniego, J. | |
| dc.contributor.author | Vega, J. de la | |
| dc.contributor.author | Sánchez-Pobre, P. | |
| dc.contributor.author | Álvarez-Navascues, C. | |
| dc.contributor.author | Carrión, José A. | |
| dc.contributor.author | Gea, F. | |
| dc.contributor.author | Morillas, R.M. | |
| dc.contributor.author | Fernández-Bermejo, M. | |
| dc.contributor.author | Castro-Iglesias, Ángeles | |
| dc.contributor.author | Rivero, M. | |
| dc.contributor.author | Fernández, J.R. | |
| dc.contributor.author | Berenguer, M. | |
| dc.contributor.author | Moreno, J.J. | |
| dc.contributor.author | Rincón, D. | |
| dc.contributor.author | Calleja-Panero, José Luis | |
| dc.contributor.author | Crespo, J. | |
| dc.date.accessioned | 2019-02-04T10:13:43Z | |
| dc.date.available | 2019-02-04T10:13:43Z | |
| dc.date.issued | 2016 | |
| dc.description | Abstract | es_ES |
| dc.identifier.citation | Cabezas J, Londoño MC, Llerena S, et al. Efficacy and safety of HCV-treatment with direct-acting antiviral agents interferon-free, in patients with severe renal impairment in clinical practice. En: International Liver Congress; 2017 Apr 19-23; Amsterdam, The Netherlands. Amsterdam: Elsevier; 2016. p, S779 (J Hepatol. 2016; 64 Suppl 2) | es_ES |
| dc.identifier.issn | 0168-8278 | |
| dc.identifier.uri | http://hdl.handle.net/2183/21654 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Elsevier | es_ES |
| dc.relation.uri | https://doi.org/10.1016/S0168-8278(16)01519-1 | es_ES |
| dc.rights | Atribución-NoComercial-SinDerivadas 3.0 España | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
| dc.title | Efficacy and safety of HCV-treatment with direct-acting antiviral agents interferon-free, in patients with severe renal impairment in clinical practice | es_ES |
| dc.type | conference output | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | f6aa3126-5f84-436d-9da4-f62438f45c9e | |
| relation.isAuthorOfPublication.latestForDiscovery | f6aa3126-5f84-436d-9da4-f62438f45c9e |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Cabezas_Efficacy.pdf
- Size:
- 138.75 KB
- Format:
- Adobe Portable Document Format
- Description:

